Quality of Earnings (QoE) in a Veterinary Practice Sale: A 2026 Seller’s Guide

Key takeaways

• A Quality of Earnings analysis is the buyer’s deep financial audit — a third-party review that tests whether your reported earnings are accurate, sustainable, and repeatable, separate from the valuation.
• The QoE is where a deal gets re-priced or confirmed. When the supportable adjusted EBITDA comes in below what was presented, the buyer can ask to lower the price, a move called a re-trade.
• An undocumented add-back is not an add-back. Buyers no longer accept an expense as non-recurring just because management labels it that way; if you can’t prove it, the QoE removes it.
• Working capital and deferred revenue quietly move money. The QoE sets a working-capital target you must leave behind, and prepaid wellness plans you owe future service on can reduce your proceeds.
• The fix is a sell-side review before you go to market — not an owner do-it-yourself project. Running the buyer’s scrutiny on your own numbers first is how you avoid surprises in diligence.

I sat with an owner over dinner last year who had already shaken hands on a number. Strong practice, real offer, the kind of result that should have closed cleanly.

He was relaxed. Then he said, almost in passing, “Their accountants are coming in to look at the books next month.

That’s just a formality, right?”

It is not a formality. That look at the books is a Quality of Earnings analysis, and it is the single most consequential financial event in a practice sale after the offer itself.

I’ve watched clean-looking deals lose hundreds of thousands of dollars in that step, and I’ve watched well-prepared owners sail through it without losing a dollar. The difference is almost never the practice.

It’s the preparation.

So let me answer the question he was really asking, because it’s the question underneath most late-stage deals.

A quality of earnings veterinary practice review, usually called a QoE, is the deep financial audit the buyer’s accountants run before closing to test whether your reported earnings are accurate, sustainable, and repeatable. It examines how you recognize revenue, rebuilds your adjusted EBITDA, scrutinizes the evidence behind every add-back, and traces your working-capital trends, per accounting-firm guidance from Anders CPA.

It is not the valuation. The valuation set the price.

The QoE decides whether that price survives. This is a sub-topic of the broader veterinary practice due diligence process, and here we go deep on the QoE specifically.

What a Quality of Earnings analysis actually is

Let me define the term cleanly before we go further. A Quality of Earnings (QoE) analysis is a third-party financial review the buyer commissions to test whether reported earnings are accurate, sustainable, and repeatable.

It is distinct from a valuation, which estimates what the practice is worth. The QoE asks a narrower, harder question: are the earnings the valuation was built on actually real?

In a veterinary practice sale specifically, the buyer’s accountants scrutinize the financial statements and the accuracy of reported earnings, per Today’s Veterinary Business. The document request is extensive: historical financials, monthly cash-flow breakdowns, detailed revenue and expense data, accounts receivable and payable reports, inventory reports, and business tax returns.

Think of it this way. Your profit-and-loss statement is a claim.

The QoE is the buyer testing that claim against every independent record they can pull, line by line, until they’re confident the number they’re paying a multiple on is the number the practice truly earns.

That’s why it matters more than owners expect. The price was a multiple of earnings.

If the QoE moves the earnings, it moves the price, and EBITDA, what your practice earns in pure operating profit, before taxes and accounting choices, is exactly the number it’s built to move.

How long does a QoE take, and what does it cost?

Two practical questions come up immediately, so let’s get them out of the way with real ranges.

A typical QoE engagement runs roughly 4 to 8 weeks, often quoted as 30 to 45 days for a standard report, per Eton Venture Services. Smaller, SMB-focused reports can turn around in 2 to 4 weeks, with rush fees adding an estimated 25 to 50 percent.

The cleaner your financials and the faster you produce documents, the shorter that window runs.

On cost, 2026 market guidance puts a QoE at roughly $15,000 to $25,000 for businesses under about $3 million of EBITDA, and $25,000 to $50,000 for $3 million to $10 million of EBITDA, per SeaRidge Advisory. Smaller deals under roughly $10 million in revenue commonly fall in the $25,000 to $35,000 range, with the largest transactions reaching six figures.

Here’s the part owners miss. On a buy-side QoE, the buyer pays for it and the buyer scopes it.

That means the analysis is run by people whose job is to find reasons the earnings might be lower than presented. The cost isn’t your concern.

The conclusion is.

What you’re asking	Directional answer (2026)	Source
How long does a QoE take?	Roughly 4 to 8 weeks; 30 to 45 days standard; 2 to 4 weeks for smaller reports	Eton Venture Services
Rush turnaround surcharge	An estimated 25 to 50 percent added	Eton Venture Services
Cost, under ~$3M EBITDA	Roughly $15,000 to $25,000	SeaRidge Advisory
Cost, $3M to $10M EBITDA	Roughly $25,000 to $50,000	SeaRidge Advisory
Who pays and scopes it	The buyer, on a standard buy-side QoE	Anders CPA
What it can change	The supportable EBITDA, and therefore the price	EBIT Community

Adjusted EBITDA: where the QoE does its real work

This is the heart of it. Almost everything a QoE touches eventually runs through one number, and getting that number right before a buyer ever sees it is the whole game.

Adjusted EBITDA, also called normalized EBITDA, is your operating profit restated to reflect what the practice would earn under a new owner. You strip out the personal and one-time items the new owner won’t carry, and you correct anything priced away from market.

In a veterinary practice, the single most important normalization is replacing the owner’s actual pay with the fair-market cost of a veterinarian to do the owner’s clinical work, per SovDoc’s veterinary valuation guidance. If you pay yourself well below what you’d pay a hired associate, your reported profit is overstated and a buyer will correct it down.

If you pay yourself far above market, the gap becomes a legitimate add-back that lifts EBITDA, if you can document it.

Other standard veterinary normalizations follow the same logic. Personal expenses run through the practice, above-market rent when you own the building, family on payroll above market, the personal auto, and genuinely one-time costs all get examined.

The principle is consistent: restate the practice as a buyer will actually operate it.

Here’s the discipline most owners underestimate. If your financials aren’t already organized around adjusted EBITDA, the buyer applies their own adjustments, and the buyer’s version almost always favors the buyer, per SovDoc.

Mixed personal and business expenses, inconsistent bookkeeping, and unexplained revenue don’t just get cleaned up neutrally. They get priced in as risk against your offer.

The add-back fight: why “non-recurring” isn’t enough anymore

If there’s one place I see owners walk into trouble, it’s add-backs. So let me be blunt about how the rules have hardened.

An add-back is an expense added back to profit because it’s personal, one-time, or above-market and won’t continue under a new owner. Add-backs raise your EBITDA, which raises your price.

That’s exactly why buyers scrutinize them.

And here’s the rule that’s changed the most. Buyers do not accept an add-back simply because management calls it non-recurring.

An undocumented add-back is not an add-back, per Anders CPA. A large majority of lenders now require detailed documentation for QoE adjustments, and most M&A transactions now involve formal financial due diligence.

The burden of proof sits squarely on the seller.

Watch what that does at scale. In one documented SMB illustration, a seller’s $315,000 of claimed add-backs was cut to roughly $165,000 to $180,000 by the QoE, pulling normalized EBITDA down from about $700,000 to roughly $460,000 to $510,000, per EBIT Community.

That example was a non-veterinary small business at a 4x multiple, lower than typical veterinary multiples, but the mechanic is identical and the leverage is the point. At a 4x multiple, a $25,000 earnings correction moves deal value by about $100,000.

Now run that same arithmetic at the multiples veterinary practices actually trade at. The leverage gets larger, not smaller.

We cover where practices land in our EBITDA benchmarks article, and the takeaway here is simple: every dollar of add-back you can’t document is a dollar of EBITDA gone, multiplied. The fix is never to claim more.

It’s to prove what you claim.

Proof of cash: the test that catches overstated revenue

There’s a quieter test inside every serious QoE, and it’s the one that separates real revenue from optimistic revenue.

A proof of cash is a reconciliation of the revenue on your profit-and-loss statement to the actual deposits in your bank account. The accountants line up what you said you earned against what actually hit the account.

A gap is a red flag. If the P&L shows $3 million in revenue but only $2.5 million was deposited, the QoE flags pulled-forward or unsupported revenue, per EBIT Community.

Documented deal-kill thresholds include EBITDA adjustments exceeding roughly 25 percent of the reported figure, revenue that won’t reconcile to deposits, or material misrepresentation.

For a practice, this is usually less about anything intentional and more about messy bookkeeping. Revenue booked in the wrong period, owner draws mixed into operating accounts, cash handling that never got cleanly reconciled.

None of it is fraud. All of it looks like risk to a buyer’s accountant who’s seeing it cold, in the middle of diligence, with no one to explain it.

That’s the case for cleaning it up first, on your own timeline, while there’s still time to fix the records rather than defend them.

Working capital and the wellness-plan liability

Here’s a part of the QoE that catches owners completely off guard, because it has nothing to do with the multiple and everything to do with what you actually pocket.

The QoE sets a working-capital peg, the normalized level of working capital you have to leave in the practice at closing so the buyer receives a functioning operation, not a stripped shell, per EBIT Community. If working capital at close falls below the peg, the buyer funds the gap dollar-for-dollar.

A $400,000 normal level against $250,000 on the balance sheet forces the buyer to cover $150,000, which effectively comes out of your proceeds.

It gets more specific in veterinary practices, because of one item that lives quietly on a lot of books: prepaid wellness plans.

A prepaid wellness plan creates a deferred-revenue obligation, money you’ve collected for services you still owe. The diligence question becomes blunt, per dvm360: do your wellness clients owe the practice money, or does the practice owe them services?

Put another way, is the buyer assuming a large liability to your existing wellness clients?

That’s not a rhetorical question in a QoE. Deferred revenue, accrued and unused vacation, and customer deposits reduce enterprise value dollar-for-dollar, because the buyer inherits every one of those obligations, per EBIT Community.

They land in the working-capital negotiation, and they come straight off the top of what you keep. Knowing your wellness-plan liability before a buyer quantifies it for you is one of the higher-leverage things you can clean up early.

The re-trade: how a QoE re-prices a deal

Now the moment owners fear, often without having a name for it. The re-trade.

A price re-trade is a request to lower the agreed price after due diligence, triggered when QoE findings reduce the supportable adjusted EBITDA below what the seller presented. The buyer can request a reduction proportional to the difference, adjust the deal structure, raise the working-capital peg, or, in extreme cases, walk, per SeaRidge Advisory.

The common triggers are exactly the items we’ve already walked through. Undocumented add-backs.

Revenue that won’t reconcile to deposits. Unaccrued liabilities.

Aging receivables. Deferred maintenance the buyer now has to fund.

Each one chips at the earnings the price was built on.

And the broader market is making this worse, not better. Through 2024 and 2025, buyer due diligence has measurably deepened: diligence exercises take longer, data rooms hold record document volumes, and a number of deals collapsed during the year over issues uncovered in diligence, per Herbert Smith Freehills Kramer’s global M&A research.

The bar for a clean, defensible earnings picture going in has risen across the board.

Here’s the asymmetry that should shape your whole approach. A re-trade happens late, when you have the least leverage, the most emotional investment, and often a single buyer in the room.

By then the competitive tension that protected your price is gone. The way to neutralize a re-trade isn’t to fight it in the moment.

It’s to make sure there’s nothing for the QoE to find.

How a seller prepares: a sell-side review, not a DIY audit

So what do you actually do about all of this? Let me be precise, because there’s a common piece of advice here that I think is wrong for owners.

A QoE is the buyer’s audit. It is not a do-it-yourself project an owner runs on a weekend with their bookkeeper.

The right preparation is a sell-side financial review, a pre-sale review built around the exact scrutiny the buyer’s accountants will apply, done before any buyer sees your numbers.

When we prepare a practice for sale, part of the work is a thorough pre-sale financial review on our side of the table, built around exactly the kind of scrutiny the buyers’ accountants will run, but before any of those buyers see your numbers. That gives us months to clean up anything that wouldn’t survive a deep audit, instead of scrambling to defend it under a diligence clock.

The benefits are concrete. A sell-side review lets you find and fix the issues a buyer would otherwise discover, builds buyer confidence when diligence starts, and can accelerate the closing timeline by an estimated 4 to 6 weeks, per SeaRidge Advisory.

You walk into the QoE with documented add-backs, reconciled cash, a known working-capital position, and a quantified wellness-plan liability, which is the opposite of walking in cold.

There’s a second, larger reason this matters, and it’s about leverage. The cleanest defense against a re-trade isn’t just clean books.

It’s not being alone in the room.

This is where the Elite Selling System does its work. We hand-select and vet every buyer who gets to bid on your practice, the way a doorman with a velvet rope lets in only the right people, then run a private competitive window inside that vetted group.

When a buyer knows there are other qualified bidders who’ve already seen the same clean numbers, the incentive to re-trade on a thin finding largely disappears. Preparation removes the ammunition; competition removes the motive.

Setting realistic expectations

Let me put this where most owners actually sit, so the picture is honest.

If your books are clean, your add-backs are documented, your revenue reconciles to your deposits, and you know your working-capital and deferred-revenue position going in, the QoE is a confirmation, not a threat. It does what it’s supposed to do: it gives the buyer confidence and lets the deal close on terms.

If your books are mixed, your add-backs are assertions rather than documented facts, and you’ve never quantified what you owe your wellness clients, the QoE is where that catches up with you. Usually it shows up as a re-trade, late, when your leverage is lowest.

Neither outcome is about how good your practice is. I’ve seen excellent practices lose real money in diligence and ordinary practices sail through it.

The variable is preparation, and preparation has a lead time measured in months, not days. We get into the full set of pre-sale moves in our guide to selling a veterinary practice and our preparing your practice for sale guide, and we cover how diligence fits the overall sale timeline.

What to do next

If you take one thing from all of this, take this: the QoE doesn’t decide whether your practice is good. It decides whether the price you were offered survives contact with a buyer’s accountants.

That outcome is set long before diligence starts, in how your numbers were prepared.

The single most useful first step is simply knowing what your defensible, normalized earnings actually are, and where the soft spots sit that a buyer’s QoE would find. That picture tells you what’s clean, what needs documentation, and what’s worth fixing in the runway before you ever go to market.

Get a Free Practice Value Estimate →

We pull your numbers ourselves, build a defensible normalized EBITDA, and run the same scrutiny a buyer’s accountants will apply, on our side of the table, before any buyer sees a thing. Then, when you’re ready, we run a competitive process that both drives the multiple and removes most of the incentive for a late re-trade.

The estimate is free and there’s no obligation to engage further. The Transitions Elite engagement model is success-based, with no upfront fees and no retainer, so we only get paid when a deal closes and only out of the value our process delivers.

---

Further reading

These are the related TE resources I’d point any vet toward as they think about diligence and a future sale. Each goes deep on one piece of the picture.

• Veterinary practice due diligence — the full diligence process the QoE sits inside.
• How to value a veterinary practice — how the price the QoE tests gets set in the first place.
• Veterinary practice EBITDA multiples — what practices actually sell for in 2026, by size and sale process.
• Tax consequences of selling a veterinary practice — the tax picture that follows a clean diligence.
• Veterinary practice letter of intent — the document that sets the price the QoE later stress-tests.
• Sell my veterinary practice — the owner’s decision guide to the whole sale.

Frequently asked questions

What is a quality of earnings report in a veterinary practice sale?

A quality of earnings (QoE) report is a third-party financial review the buyer commissions before closing to test whether a practice’s reported earnings are accurate, sustainable, and repeatable. It examines revenue recognition, adjusted EBITDA, working capital, and the documentation behind every add-back.

It is the buyer’s deep financial audit, separate from the valuation, and it is where a deal is most often re-priced or confirmed.

How long does a quality of earnings analysis take?

A typical QoE engagement runs roughly 4 to 8 weeks, often quoted as 30 to 45 days for a standard report. Smaller, SMB-focused reports can turn around in 2 to 4 weeks, with rush fees adding an estimated 25 to 50 percent.

Timelines vary with deal complexity, the cleanliness of the financials, and how quickly the seller produces requested documents.

How much does a quality of earnings report cost in 2026?

Market guidance for 2026 puts a QoE at roughly $15,000 to $25,000 for businesses under about $3 million of EBITDA, and $25,000 to $50,000 for $3 million to $10 million of EBITDA. Smaller businesses under roughly $10 million in revenue commonly fall in the $25,000 to $35,000 range, with the largest deals reaching six figures.

Costs vary by provider and scope and are directional, not fixed.

What does a buyer’s QoE test in a veterinary practice?

The buyer’s accountants test revenue recognition, the accuracy of reported earnings, adjusted EBITDA, working-capital trends, and the evidence behind every add-back. They request historical financials, cash-flow detail, revenue and expense breakdowns, accounts receivable and payable, inventory reports, and tax returns.

They run a proof-of-cash test reconciling revenue to bank deposits and quantify deferred-revenue obligations such as prepaid wellness plans.

Why do buyers reject EBITDA add-backs?

Buyers do not accept an add-back simply because management labels it non-recurring. An undocumented add-back is not an add-back.

Each one must be substantiated with documentation, and a large majority of lenders now require detailed support for QoE adjustments. When add-backs cannot be proven, the QoE removes them, which lowers supportable EBITDA and, at the practice’s multiple, can move deal value substantially.

What is a working-capital peg in a practice sale?

A working-capital peg is the normalized level of working capital the QoE sets as the target a seller must leave in the practice at closing, so the buyer receives a functioning operation rather than a stripped shell. If working capital at close falls below the peg, the buyer funds the gap dollar-for-dollar, which reduces seller proceeds.

Deferred revenue, unused vacation, and customer deposits typically reduce value because the buyer inherits those obligations.

What is a price re-trade and what triggers one?

A price re-trade is a request to lower the agreed price after due diligence, triggered when QoE findings reduce supportable adjusted EBITDA below what was presented. The buyer requests a reduction proportional to the difference, adjusts structure, raises the working-capital peg, or, in extreme cases, walks.

Common triggers include undocumented add-backs, revenue that does not reconcile to deposits, unaccrued liabilities, aging receivables, and deferred maintenance.

Should a veterinary practice owner get their own QoE before selling?

This is not a do-it-yourself exercise for an owner. The practical answer is a sell-side financial review done as part of sale preparation, built around the exact scrutiny the buyer’s accountants will apply, but before any buyer sees the numbers.

At Transitions Elite we run that review on our side of the table during preparation, which gives us months to fix anything that would not survive a deep audit and to enter due diligence with a clean, defensible earnings picture.

---

Sources

Quality of earnings methodology and due diligence

1. Anders CPA. “Quality of Earnings Report Analysis: A Due Diligence Guide.” anderscpa.com
2. Eton Venture Services. “Quality of Earnings.” etonvs.com
3. SeaRidge Advisory. “Quality of Earnings (QofE) Checklist and Guide.” searidgeadvisory.com
4. EBIT Community. “Quality of Earnings Reports for Small Business Acquisitions.” ebitcommunity.com
5. Baker Tilly. “Quality of Earnings Report.” bakertilly.com
6. Doeren Mayhew. “Understanding a Quality of Earnings Report in Pre-Sale Due Diligence.” doeren.com

Veterinary practice sale, valuation, and operations

7. Today’s Veterinary Business. “Veterinary Practice Sale Legal Lingo.” todaysveterinarybusiness.com
8. SovDoc. “How to Value a Veterinary or Animal Health Practice.” sovdoc.com
9. dvm360. “A Skeptic’s Guide to Veterinary Wellness Plans.” dvm360.com

M&A market context

10. Herbert Smith Freehills Kramer. “Global M&A Report 2025: Due Diligence Deeper Dives.” hsfkramer.com
11. Moss Adams. “Quality of Earnings Report.” mossadams.com